Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-11-11 Sale | 2022-11-15 5:01 pm | CATALYST PHARMACEUTICALS INC. | CPRX | Sundaram Preethi Chief Strategy Officer | 56,786 | $16.38 | $929,871 | 342,500 (Direct) | View |
| 2022-09-15 Sale | 2022-09-16 5:01 pm | CATALYST PHARMACEUTICALS INC. | CPRX | Sundaram Preethi Chief Strategy Officer | 18,214 | $14.49 | $263,921 | 399,286 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-15 Exercise | 2024-02-16 5:00 pm | N/A N/A | CATALYST PHARMACEUTICALS INC. | CPRX | Sundaram Preethi Chief Strategy Officer | 16,667 | $0 | 579,800 (Direct) | View |
| 2024-02-15 Tax Withholding | 2024-02-16 5:00 pm | N/A N/A | CATALYST PHARMACEUTICALS INC. | CPRX | Sundaram Preethi Chief Strategy Officer | 6,025 | $0 | 579,800 (Direct) | View |
| 2023-12-27 Exercise | 2023-12-29 5:00 pm | N/A N/A | CATALYST PHARMACEUTICALS INC. | CPRX | Sundaram Preethi Chief Strategy Officer | 6,666 | $0 | 585,825 (Direct) | View |
| 2023-12-27 Tax Withholding | 2023-12-29 5:00 pm | N/A N/A | CATALYST PHARMACEUTICALS INC. | CPRX | Sundaram Preethi Chief Strategy Officer | 2,409 | $0 | 585,825 (Direct) | View |
| 2023-12-08 Option Award | 2023-12-12 5:00 pm | N/A 2030-12-08 | CATALYST PHARMACEUTICALS INC. | CPRX | Sundaram Preethi Chief Strategy Officer | 163,758 | $0 | 1,134,619 (Direct) | View |
| 2023-02-15 Exercise | 2023-02-17 5:01 pm | N/A N/A | CATALYST PHARMACEUTICALS INC. | CPRX | Sundaram Preethi Chief Strategy Officer | 16,666 | $0 | 424,476 (Direct) | View |
| 2023-02-15 Tax Withholding | 2023-02-17 5:01 pm | N/A N/A | CATALYST PHARMACEUTICALS INC. | CPRX | Sundaram Preethi Chief Strategy Officer | 6,024 | $0 | 424,476 (Direct) | View |
| 2022-12-27 Option Award | 2022-12-29 4:49 pm | N/A 2029-12-27 | CATALYST PHARMACEUTICALS INC. | CPRX | Sundaram Preethi Chief Strategy Officer | 88,000 | $0 | 841,000 (Direct) | View |
| 2022-11-11 Exercise | 2022-11-15 5:01 pm | N/A N/A | CATALYST PHARMACEUTICALS INC. | CPRX | Sundaram Preethi Chief Strategy Officer | 56,786 | $5.49 | 342,500 (Direct) | View |
| 2022-11-11 Exercise | 2022-11-15 5:01 pm | 2022-07-06 2028-07-06 | CATALYST PHARMACEUTICALS INC. | CPRX | Sundaram Preethi Chief Strategy Officer | 56,786 | $0 | 342,500 (Direct) | View |
| 2022-09-15 Exercise | 2022-09-16 5:01 pm | N/A N/A | CATALYST PHARMACEUTICALS INC. | CPRX | Sundaram Preethi Chief Strategy Officer | 18,214 | $5.49 | 399,286 (Direct) | View |
| 2022-09-15 Exercise | 2022-09-16 5:01 pm | 2022-07-06 2028-07-06 | CATALYST PHARMACEUTICALS INC. | CPRX | Sundaram Preethi Chief Strategy Officer | 18,214 | $0 | 399,286 (Direct) | View |
| 2022-02-14 Option Award | 2022-02-16 5:05 pm | N/A N/A | CATALYST PHARMACEUTICALS INC. | CPRX | Sundaram Preethi Chief Strategy Officer | 50,000 | $0 | 417,500 (Direct) | View |
| 2021-12-28 Option Award | 2021-12-30 4:50 pm | N/A 2028-12-28 | CATALYST PHARMACEUTICALS INC. | CPRX | Sundaram Preethi Chief Product Devel. Officer | 67,500 | $0 | 367,500 (Direct) | View |
Ownership | 2021-07-13 4:44 pm | N/A 2028-07-06 | CATALYST PHARMACEUTICALS INC. | CPRX | Sundaram Preethi Chief Product Devel. Officer | 0 | $0 | 300,000 (Direct) | View |